Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7516 | 1360 | 34.6 | 71% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
337 | 3 | IRRITABLE BOWEL SYNDROME//CONSTIPATION//ENTERIC NERVOUS SYSTEM | 37464 |
111 | 2 | IRRITABLE BOWEL SYNDROME//NEUROGASTROENTEROLOGY AND MOTILITY//FUNCTIONAL DYSPEPSIA | 25141 |
7516 | 1 | 5 HT4 RECEPTOR//5 HT4//GR 113808 | 1360 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | 5 HT4 RECEPTOR | authKW | 2884127 | 14% | 68% | 190 |
2 | 5 HT4 | authKW | 514290 | 3% | 55% | 42 |
3 | GR 113808 | authKW | 424152 | 2% | 82% | 23 |
4 | 5 HT4 RECEPTOR AGONIST | authKW | 391122 | 2% | 62% | 28 |
5 | MOSAPRIDE | authKW | 317481 | 2% | 43% | 33 |
6 | SEROTONIN 5 HT4 RECEPTOR | authKW | 246959 | 1% | 100% | 11 |
7 | CISAPRIDE | authKW | 237512 | 5% | 17% | 64 |
8 | MOSAPRIDE CITRATE | authKW | 202599 | 1% | 48% | 19 |
9 | GR 125487 | authKW | 202057 | 1% | 100% | 9 |
10 | GASTROPROKINETIC AGENT | authKW | 194034 | 1% | 79% | 11 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 11289 | 53% | 0% | 720 |
2 | Chemistry, Medicinal | 2235 | 13% | 0% | 171 |
3 | Gastroenterology & Hepatology | 1971 | 12% | 0% | 165 |
4 | Neurosciences | 439 | 13% | 0% | 174 |
5 | Veterinary Sciences | 94 | 4% | 0% | 55 |
6 | Chemistry, Organic | 82 | 5% | 0% | 71 |
7 | Medicine, Research & Experimental | 74 | 4% | 0% | 54 |
8 | Physiology | 51 | 3% | 0% | 43 |
9 | Chemistry, Analytical | 23 | 3% | 0% | 46 |
10 | Clinical Neurology | 21 | 3% | 0% | 46 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RECONNAISSANCE MOL CELLULAIRE | 71841 | 0% | 80% | 4 |
2 | DISCOVERY PHARMACOL GRP 2 | 59866 | 0% | 67% | 4 |
3 | RECONNAISSANCE MOL SYNTH | 50513 | 0% | 75% | 3 |
4 | CARDIOL CELLULAIRE MOL | 46615 | 1% | 23% | 9 |
5 | GI PHARMACOL | 44902 | 0% | 100% | 2 |
6 | GASTROINTESTINAL PHARMACOL | 41041 | 1% | 23% | 8 |
7 | HEYMANS PHARMACOL | 31419 | 2% | 6% | 24 |
8 | BIOMED BIOTECNOL IBBTEC | 29933 | 0% | 67% | 2 |
9 | DRUG DISCOVERY AS | 29933 | 0% | 67% | 2 |
10 | CNRS UPR 9023 | 28862 | 0% | 43% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 10354 | 4% | 1% | 53 |
2 | BRITISH JOURNAL OF PHARMACOLOGY | 9728 | 6% | 1% | 88 |
3 | NEUROGASTROENTEROLOGY AND MOTILITY | 4977 | 2% | 1% | 24 |
4 | JAPANESE JOURNAL OF PHARMACOLOGY | 4268 | 2% | 1% | 29 |
5 | EUROPEAN JOURNAL OF PHARMACOLOGY | 3830 | 5% | 0% | 70 |
6 | JOURNAL OF GASTROINTESTINAL MOTILITY | 3322 | 0% | 7% | 2 |
7 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2388 | 4% | 0% | 48 |
8 | JOURNAL OF PHARMACY AND PHARMACOLOGY | 1714 | 2% | 0% | 25 |
9 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1661 | 1% | 0% | 19 |
10 | SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1638 | 2% | 0% | 27 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | 5 HT4 RECEPTOR | 2884127 | 14% | 68% | 190 | Search 5+HT4+RECEPTOR | Search 5+HT4+RECEPTOR |
2 | 5 HT4 | 514290 | 3% | 55% | 42 | Search 5+HT4 | Search 5+HT4 |
3 | GR 113808 | 424152 | 2% | 82% | 23 | Search GR+113808 | Search GR+113808 |
4 | 5 HT4 RECEPTOR AGONIST | 391122 | 2% | 62% | 28 | Search 5+HT4+RECEPTOR+AGONIST | Search 5+HT4+RECEPTOR+AGONIST |
5 | MOSAPRIDE | 317481 | 2% | 43% | 33 | Search MOSAPRIDE | Search MOSAPRIDE |
6 | SEROTONIN 5 HT4 RECEPTOR | 246959 | 1% | 100% | 11 | Search SEROTONIN+5+HT4+RECEPTOR | Search SEROTONIN+5+HT4+RECEPTOR |
7 | CISAPRIDE | 237512 | 5% | 17% | 64 | Search CISAPRIDE | Search CISAPRIDE |
8 | MOSAPRIDE CITRATE | 202599 | 1% | 48% | 19 | Search MOSAPRIDE+CITRATE | Search MOSAPRIDE+CITRATE |
9 | GR 125487 | 202057 | 1% | 100% | 9 | Search GR+125487 | Search GR+125487 |
10 | GASTROPROKINETIC AGENT | 194034 | 1% | 79% | 11 | Search GASTROPROKINETIC+AGENT | Search GASTROPROKINETIC+AGENT |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LANGLOIS, M , FISCHMEISTER, R , (2003) 5-HT4 RECEPTOR LIGANDS: APPLICATIONS AND NEW PROSPECTS.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 46. ISSUE 3. P. 319-344 | 159 | 76% | 69 |
2 | BUREAU, R , BOULOUARD, M , DAUPHIN, F , LEZOUALC'H, F , RAULT, S , (2010) REVIEW OF 5-HT4R LIGANDS: STATE OF ART AND CLINICAL APPLICATIONS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 5. P. 527-553 | 84 | 76% | 7 |
3 | LUCAS, G , (2009) SEROTONIN RECEPTORS, TYPE 4: A NEW HOPE?.CURRENT DRUG TARGETS. VOL. 10. ISSUE 11. P. 1085-1095 | 71 | 72% | 10 |
4 | DE MAEYER, JH , LEFEBVRE, RA , SCHUURKES, JAJ , (2008) 5-HT4 RECEPTOR AGONISTS: SIMILAR BUT NOT THE SAME.NEUROGASTROENTEROLOGY AND MOTILITY. VOL. 20. ISSUE 2. P. 99-112 | 66 | 59% | 124 |
5 | BRIEJER, MR , AKKERMANS, LMA , SCHUURKES, JAJ , (1995) GASTROINTESTINAL PROKINETIC BENZAMIDES: THE PHARMACOLOGY UNDERLYING STIMULATION OF MOTILITY.PHARMACOLOGICAL REVIEWS. VOL. 47. ISSUE 4. P. 631-651 | 87 | 68% | 123 |
6 | STANGHELLINI, V , TACK, J , CAMILLERI, M , CHANG, L , CHEY, WD , GALLIGAN, JJ , LACY, BE , MULLER-LISSNER, S , QUIGLEY, EMM , SCHUURKES, J , ET AL (2012) SYSTEMATIC REVIEW: CARDIOVASCULAR SAFETY PROFILE OF 5-HT4 AGONISTS DEVELOPED FOR GASTROINTESTINAL DISORDERS.ALIMENTARY PHARMACOLOGY & THERAPEUTICS. VOL. 35. ISSUE 7. P. 745 -767 | 73 | 38% | 72 |
7 | NIROGI, R , KANDIKERE, V , BHYRAPUNENI, G , SARALAYA, R , AJJALA, DR , ALETI, RR , RASHEED, MA , (2013) IN-VIVO RAT STRIATAL 5-HT4 RECEPTOR OCCUPANCY USING NON-RADIOLABELLED SB207145.JOURNAL OF PHARMACY AND PHARMACOLOGY. VOL. 65. ISSUE 5. P. 704-712 | 35 | 78% | 4 |
8 | NIROGI, R , MOHAMMED, AR , SHINDE, AK , BOGARAJU, N , GAGGINAPALLI, SR , RAVELLA, SR , KOTA, L , BHYRAPUNENI, G , MUDDANA, NR , BENADE, V , ET AL (2015) SYNTHESIS AND SAR OF IMIDAZO[1,5-A]PYRIDINE DERIVATIVES AS 5-HT4 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF COGNITIVE DISORDERS ASSOCIATED WITH ALZHEIMER'S DISEASE.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 103. ISSUE . P. 289 -301 | 30 | 79% | 2 |
9 | DE MAEYER, JH , STRAETEMANS, R , SCHUURKES, JAJ , LEFEBVRE, RA , (2006) PORCINE LEFT ATRIAL AND SINOATRIAL 5-HT4 RECEPTOR-INDUCED RESPONSES: FADING OF THE RESPONSE AND INFLUENCE OF DEVELOPMENT.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 147. ISSUE 2. P. 140-157 | 43 | 64% | 24 |
10 | VICKERY, RG , MAI, N , KAUFMAN, E , BEATTIE, DT , PULIDO-RIOS, T , O'KEEFE, M , HUMPHREY, PPA , SMITH, JAM , (2007) A COMPARISON OF THE PHARMACOLOGICAL PROPERTIES OF GUINEA-PIG AND HUMAN RECOMBINANT 5-HT4 RECEPTORS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 150. ISSUE 6. P. 782 -791 | 37 | 74% | 10 |
Classes with closest relation at Level 1 |